1. Chi3L1 is a therapeutic target in bone metabolism and a potential clinical marker in patients with osteoporosis. (October 2022) Authors: Park, Kyung-Ran; Park, Jae-Il; Lee, Seongsoo; Yoo, Kyeongwon; Kweon, Gi-Ryang; Kwon, Il Keun; Yun, Hyung-Mun; Hong, Jin Tae Journal: Pharmacological research Issue: Volume 184(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗